New Publication / 2025
Fraunhofer ITEM contributes to innovative model study on inflammatory bowel disease
Approximately five million people worldwide suffer from chronic inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. Despite modern therapies, many immunological mechanisms underlying the disease remain poorly understood – posing a key challenge for the development of new targeted treatments.
more info